GoodRx Announces Significant Savings on Antivirals, Medications and Vaccines for Cold & Flu Season
Company saved Americans more than
For live updates on the progression and treatment rates of the flu, COVID-19 and RSV, check out GoodRx’s “Tripledemic” Tracker.
Big Savings on Flu Shots
The best way for consumers to protect themselves against the flu is to get the annual flu shot between September and the end of October, notes the
To make flu shots more accessible to all Americans this season,
6 months to 64 years: Under
$40for the Fluarix or Fluzone Quadrivalent
65 years and older: Under
$70for the Fluzone High-Dose Quadrivalent
Cold & Flu Treatments
For those who get the flu this season,
Avg % Savings
(Pricing information based on
COVID-19 & RSV
In addition to cold and flu,
- Anyone six months and older should receive an annual flu shot by the end of October. Those 65 and older should get the high-dose version.
- Adults with high-risk conditions and those 60 years and older should talk to their healthcare providers about the RSV vaccine, as they may be more susceptible to complications from the virus.
Parents of babies under the age of 8 months, or of babies ages 8 - 19 months old with high risk medical conditions, should talk to their pediatrician about getting the newly approved RSV antibody vaccine, starting
The flu and COVID vaccines can ideally be taken together, but
Dr. Parikhrecommends spacing out the RSV vaccine until more data is available to confirm that taking them together won’t decrease their efficacy.
Expert Advice from
To help consumers better navigate this year’s “tripledemic,”
- COVID, Flu, and RSV: Your GoodRx Guide to Getting Vaccinated this Fall
- COVID-19: Your GoodRx Guide
- Flu Vaccines: Your GoodRx Guide
- How to Find the COVID-19 Pills Paxlovid and Lagevrio
- RSV Vaccines: How Abrysvo vs. Arexvy Compare
- RSV: Your GoodRx Guide to Symptoms and Treatment
To learn more about how
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding consumer savings and the benefits of our offerings to consumers. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks relating to our ability to achieve broad market education and change consumer purchasing habits, changes in medication pricing and pricing structures, our reliance on a limited number of industry participants, the competitive nature of our industry, risks related to government regulation of the internet, e-commerce, consumer data and privacy, information technology and cyber-security and the important factors discussed in the sections entitled “Risk Factors” in GoodRx’s Annual Report on Form 10-K for the year ended